Ma Grace X, Seals Brenda, Tan Yin, Wang Sylvia Y, Lee Richard, Fang Carolyn Y
a Center for Asian Health, College of Health Professions, Temple University, Philadelphia, PA, USA.
b Department of Public Health, College of Health Professions, Temple University, Philadelphia, PA, USA.
Clin Trials. 2014 Jun;11(3):328-335. doi: 10.1177/1740774514522561.
Background Asian Americans are underrepresented in clinical trials, but little is known about the factors that contribute to clinical trial participation in this population. Purpose The purpose of this study was to identify knowledge, barriers, facilitators, and cultural influences on participating in clinical trials among three Asian American ethnic groups. Concurrently, we sought to identify mechanisms and messages to facilitate dissemination of information and to identify strategies to promote clinical trial participation in this population. Methods Eight focus groups were conducted (n = 103) with Chinese (four groups), Korean (two groups), and Vietnamese (two groups) Americans. Each group was conducted with a moderator and a translator using a standardized guide. Results Participants discuss the benefits of contributing to science, future generations, and their families by being in clinical trials. Some participants think clinical trials would give hope to those with terminal illnesses. A doctor's recommendation, being sick, and needing more options for treatment are motivators for Asian Americans. Having some guarantee of treatment effectiveness and lack of side effects facilitates participation. Cultural or religious beliefs are not believed to prevent clinical trial participation. Limitations This qualitative, two-site study included three Asian American ethnic groups and is not meant to establish prevalence of beliefs. Conclusion Asian Americans need more information about clinical trials and their benefits to science and the larger community. Health-care providers can play pivotal roles in enhancing recruitment of Asian Americans. Basing recruitment goals on percentage representation in most US geographic areas does not provide sufficient numbers to allow for analysis of minorities like Asian American groups. The discovery of important group-specific harms and benefits depends on greater participation of racial/ethnic subgroups.
亚裔美国人在临床试验中的代表性不足,但对于影响该人群参与临床试验的因素知之甚少。目的:本研究旨在确定影响三个亚裔美国种族群体参与临床试验的知识、障碍、促进因素和文化影响。同时,我们试图确定促进信息传播的机制和信息,并确定促进该人群参与临床试验的策略。方法:对华裔美国人(四组)、韩裔美国人(两组)和越南裔美国人(两组)进行了8个焦点小组访谈(n = 103)。每个小组由一名主持人和一名翻译使用标准化指南进行访谈。结果:参与者讨论了参与临床试验对科学、后代和家庭的益处。一些参与者认为临床试验会给绝症患者带来希望。医生的推荐、患病以及需要更多治疗选择是亚裔美国人参与临床试验的动机。对治疗效果有一定保证且无副作用有助于参与。文化或宗教信仰不被认为会阻碍参与临床试验。局限性:这项定性的双地点研究包括三个亚裔美国种族群体,并非旨在确定信仰的普遍性。结论:亚裔美国人需要更多关于临床试验及其对科学和更广泛社区益处的信息。医疗保健提供者在增加亚裔美国人的招募方面可以发挥关键作用。根据美国大多数地理区域的代表性百分比设定招募目标,无法提供足够数量的数据以对亚裔美国人群体等少数群体进行分析。发现重要的群体特异性危害和益处取决于种族/族裔亚组的更多参与。